News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website


Oncolytics Biotech Inc. Announces Results of REOLYSIN Treatment of Brain Cancer --Gliomas-- in Animal Models (Business Wire)...~~~) reported today that Dr. Peter Forsyth and his research group with the Alberta Cancer Board and the University of Calgary are publishing the results of their work with REOLYSIN(R) for the treatment of human malignant gliomas (brain cancer) in animal models.......The research group also examined the ability of REOLYSIN(R) to infect and kill cancer cells from established glioma cell lines and brain tumor surgical specimens.......~~~Oncolytics has completed the initial part of formal toxicology studies examining the effects of injecting REOLYSIN(R) into the brains of test animals and have found no side effects of note.......Oncolytics researchers demonstrated that reovirus was selectively able to kill cancer cells with this particular activation and successfully demonstrated that the virus could kill human cancer cells in vitro derived from breast, prostate, pancreatic and brain tumors, as well as being able to treat tumours successfully in a number of animal models....- Jun 19 4:00 PM ET

IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source:

(Everything below this line is from!)

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557